Bertrand Clinical Label
Biotech companies are evolving. The new way of doing business is to outsource everything, but top-level management. This reduces costs and cash burn dramatically giving you more time to prove your IMP. Companies with great innovations to pursue and lower cash burn are more attractive to venture capital.
Bertrand Clinical Label (BCL) fits perfectly into the virtual biotech strategy. We are seeing an uptrend in companies that are buying the components - the research - the packaging - the labeling, etc. all separately. This eliminates two areas of major costs - building your own plant and equipment or buying it from a one-stop shop and overpaying.
We offer the following advantages:
A virtual biotech outsources all manufacturing operations including labeling and packaging, retaining only top-level management, to reduce costs and accelerate drug development timelines.
We offer direct communication with no middle agency, faster process speeds, label design input during early study stages, and no multiple markups since you buy directly from the manufacturer.
By eliminating intermediaries, you avoid multiple markups and reduce total label costs significantly versus buying through a CMO or CPO.
Yes. If your CPO is not already an approved BCL supplier, you can specify BCL in your contract and we will work through the approval process together.
We are located next to Buffalo Niagara International Airport making on-site audits very convenient. Virtual audits are also available.
